Karin Jooss, EVP, Head of Research and Development at Gritstone bio, holds 683.53K shares in Gritstone bio (Ticker: GRTSQ), holds 9.85K shares in Fate Therapeutics (Ticker: FATE).
What is the percentage of profitable transactions made by Karin Jooss?
The percentage of profitable transactions made by Karin Jooss is 100%.
What is the average return per transaction made by Karin Jooss?
The average return per transaction made by Karin Jooss is 85.50%.
What stocks does Karin Jooss hold?
Karin Jooss holds: GRTSQ, FATE stocks.
What was Karin Jooss’s latest transaction?
Karin Jooss latest transaction was an Uninformative Buy of ―.
What was Karin Jooss's most profitable transaction?
Karin Jooss’s most profitable transaction was an Informative Sell of GRTSQ stock on May 17, 2024. The return on the trade was 96.10%.
What is Karin Jooss's role in Gritstone bio?
Karin Jooss's role in Gritstone bio is EVP, Head of Research and Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.